CTI BioPharma Corp. (NASDAQ:CTIC) saw a large decrease in short interest in the month of October. As of October 14th, there was short interest totalling 533,910 shares, a decrease of 25.6% from the September 30th total of 718,038 shares. Approximately 0.2% of the shares of the company are sold short. Based on an average daily […]
